BIO-UV Group S.A. (EPA:ALTUV)
France · Delayed Price · Currency is EUR 1.340
-0.010 (-0.74%)
Aug 21, 2026, 5:35 PM CET
BIO-UV Group Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 35.91 | 39.58 | 43.13 | 51.29 | 33.46 |
Other Revenue | 0.96 | -0.89 | -1.02 | - | 1.82 |
| 36.87 | 38.69 | 42.12 | 51.29 | 35.28 | |
Revenue Growth | -4.69% | -8.14% | -17.88% | 45.38% | 7.01% |
Cost of Revenue | 12.94 | 14.6 | 16.54 | 23.13 | 14.58 |
Gross Profit | 23.93 | 24.09 | 25.58 | 28.16 | 20.7 |
Selling, General & Admin | 9.61 | 9.43 | 9.44 | 9.38 | 7.67 |
Other Operating Expenses | 9.65 | 8.83 | 10.17 | 11.43 | 9.05 |
Operating Expenses | 22.38 | 21.96 | 23.28 | 24.03 | 19.7 |
Operating Income | 1.55 | 2.13 | 2.3 | 4.13 | 1 |
Interest Expense | -0.76 | -0.78 | -1.02 | -0.68 | -0.36 |
Interest & Investment Income | 0 | 0 | 0 | 0.02 | 0.04 |
Currency Exchange Gain (Loss) | -0.01 | -0 | 0.01 | -0.13 | 0.05 |
Other Non Operating Income (Expenses) | 0.12 | -0.19 | -0.31 | -0 | 0.01 |
EBT Excluding Unusual Items | 0.9 | 1.16 | 0.97 | 3.34 | 0.74 |
Legal Settlements | -0 | -1.07 | -0.39 | -0.06 | -0.14 |
Other Unusual Items | - | -0.01 | -0.56 | -0.28 | 0.04 |
Pretax Income | 0.9 | 0.09 | 0.02 | 3 | 0.63 |
Income Tax Expense | 0.07 | 0.06 | -0.11 | 0.58 | -0.06 |
Earnings From Continuing Operations | 0.84 | 0.03 | 0.12 | 2.42 | 0.69 |
Net Income | 0.84 | 0.03 | 0.12 | 2.42 | 0.69 |
Net Income to Common | 0.84 | 0.03 | 0.12 | 2.42 | 0.69 |
Net Income Growth | 2566.80% | -74.89% | -94.84% | 250.74% | 18.05% |
Shares Outstanding (Basic) | 14 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 14 | 10 | 10 | 10 | 10 |
Shares Change | 33.08% | 0.44% | 2.44% | 0.21% | 18.05% |
EPS (Basic) | 0.06 | 0.00 | 0.01 | 0.24 | 0.07 |
EPS (Diluted) | 0.06 | 0.00 | 0.01 | 0.24 | 0.07 |
EPS Growth | 1903.93% | -75.00% | -94.96% | 250.00% | 0% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.99 | 4.96 | 4.28 | 0.48 | 0.57 |
Free Cash Flow Per Share | 0.21 | 0.47 | 0.41 | 0.05 | 0.06 |
Dividend Per Share | - | - | - | 0.039 | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 64.91% | 62.28% | 60.72% | 54.90% | 58.68% |
Operating Margin | 4.21% | 5.51% | 5.46% | 8.06% | 2.83% |
Profit Margin | 2.27% | 0.08% | 0.30% | 4.71% | 1.95% |
Free Cash Flow Margin | 8.11% | 12.83% | 10.15% | 0.93% | 1.62% |
EBITDA | 2.21 | 2.69 | 2.59 | 4.58 | 1.38 |
EBITDA Margin | 5.99% | 6.96% | 6.14% | 8.92% | 3.91% |
D&A For EBITDA | 0.66 | 0.56 | 0.29 | 0.44 | 0.38 |
EBIT | 1.55 | 2.13 | 2.3 | 4.13 | 1 |
EBIT Margin | 4.21% | 5.51% | 5.46% | 8.06% | 2.83% |
Effective Tax Rate | 7.25% | 66.02% | - | 19.28% | - |